Work

Immune‐Mediated Thrombocytopenia in an Ulcerative Colitis Patient After Initiating Filgotinib Treatment: A Case Report

Year: 2025

Type: article

Abstract: Moderate-to-severe ulcerative colitis can be effectively treated with JAK-1 inhibition, but platelet counts should be closely monitored, especially in active disease. We confirmed immune-mediated thrombocytopenia (ITP) in one of our patients after the initiation of filgotinib. Whether this was drug-induced is uncertain.

Source: Clinical Case Reports

DOI: 10.1002/ccr3.71574

Authors: M. J. van der Hoff, F. El‐Morabit, M. Löwenberg

Institutions: Amsterdam University Medical Centers, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam UMC Location Vrije Universiteit Amsterdam

Language: English

Topic: Platelet Disorders and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,820